These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 12659083

  • 1. Delayed side effects induced by iodinated contrast media, especially those associated with iodixanol.
    Idée JM, Corot C.
    Eur Radiol; 2003 Mar; 13(3):644-5; author reply 645. PubMed ID: 12659083
    [No Abstract] [Full Text] [Related]

  • 2. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
    Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
    [Abstract] [Full Text] [Related]

  • 3. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.
    JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients.
    Denardo SJ, Vock DM, Schmalfuss CM, Young GD, Tcheng JE, O'Connor CM.
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27382090
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
    Deray G.
    J Am Coll Cardiol; 2007 Apr 17; 49(15):1668. PubMed ID: 17433961
    [No Abstract] [Full Text] [Related]

  • 8. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW, Dukovic D, Pagani E.
    Acad Radiol; 1995 Jan 17; 2(1):33-7. PubMed ID: 9419521
    [Abstract] [Full Text] [Related]

  • 9. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
    Persson P, Liss P, Hansell P.
    J Am Coll Cardiol; 2007 Apr 17; 49(15):1668-1669. PubMed ID: 17433962
    [No Abstract] [Full Text] [Related]

  • 10. Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?
    Jo SH, Koo BK, Youn TJ, Kim HS.
    Kidney Int; 2007 Apr 17; 71(8):828; author reply 828-9. PubMed ID: 17429424
    [No Abstract] [Full Text] [Related]

  • 11. Incompatibility of contrast medium and trisodium citrate.
    Delcour C, Bruninx G.
    Cardiovasc Intervent Radiol; 2013 Feb 17; 36(1):237-8. PubMed ID: 22696011
    [Abstract] [Full Text] [Related]

  • 12. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 13. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC, Wu Q, Wang C, Li DY, Wang ZR.
    J Cardiol; 2014 Apr 26; 63(4):260-8. PubMed ID: 24397991
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fixed drug eruption caused by iodixanol].
    Le Beller C, Fraitag S, Jacquot C, Lillo-Le Louët A, Auffret N.
    Ann Dermatol Venereol; 2008 Oct 26; 135(10):684-5. PubMed ID: 18929921
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-osmolality contrast media-induced ventricular fibrillation.
    Hayakawa K, Yamashita K.
    Invest Radiol; 1989 Apr 26; 24(4):298-301. PubMed ID: 2745010
    [Abstract] [Full Text] [Related]

  • 18. Drug eruptions to contrast media in Japan.
    Nakada T, Akiyama M, Iijima M, Kato A, Maibach HI.
    Clin Exp Dermatol; 2006 May 26; 31(3):361-4. PubMed ID: 16681576
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fixed drug eruption caused by iodinated contrast media.
    Frías M, Fernández E, Audicana MT, Longo N, Muñoz D, Reyes SM.
    Contact Dermatitis; 2011 Jul 26; 65(1):43-4. PubMed ID: 21658055
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.